R&D

Breaking News | Collaborations & Alliances | R&D

BridgeBio Pharma Enters Genetic Disease Alliance

Research collaboration aims to identify and develop genetic disease therapies

11.12.18

PPD Discusses Lab Trends

Heather Myler, Director R&D, Immunochemistry, PPD discusses trends, including the increase of new modalities in the industry

Videos

Sharp, BSM Enter Agreement

Sharp will offer sterile fill/finish to augment its existing clinical manufacturing service to several sectors

11.09.18

Sanofi, Denali Enter Collaboration

For the development of multiple molecules with the potential to treat certain neurological & systemic inflammatory diseases

11.01.18

GW Pharmaceuticals' EPIDIOLEX Now Available in U.S.

First prescription pharmaceutical formulation of highly purified CBD and the first in a new category of anti-epileptic drugs

11.01.18

Bio News | Clinical Trials | Industry News | R&D | Trials & Filings

Janssen Receives FDA Approval for INVOKANA

To reduce risk of major adverse cardiovascular events, in adults with type 2 diabetes (T2D) who have established CV disease

10.30.18

Novartis, Pfizer Partner for NASH

A complex condition with no available treatment options, NASH affects up to 6.5% of the population worldwide

10.29.18

Lilly, Dicerna Announce Global Licensing Agreement

For the discovery, development & commercialization of medicines for cardio-metabolic disease, neurodegeneration, and pain

10.29.18

Adesis Officially Opens Delaware Lab

The 50,000 sq. ft site opens after an expansion of 6,000 square feet was added to the existing chemistry labs

10.26.18

Bio News | Collaborations & Alliances | Drug Development | Industry News | R&D

Idifarma, Palobiofarma Enter Partnership

Under the agreement, Idifarma will handle the full pharmaceutical development of Palobiofarma’s PBF-2897

10.26.18

Daiichi Sankyo, Merck, Pfizer Enter Collaboration

To evaluate the combination of [fam-] trastuzumab deruxtecan in combination with the checkpoint inhibitor avelumab

10.25.18

AbbVie Takes Over Galapagos Collaboration

Will assume full development & commercial responsibility for its collaboration with Galapagos for cystic fibrosis treatments

10.25.18

COMPASS Pathways Receives Breakthrough Therapy Designation

From the FDA for its psilocybin therapy for treatment-resistant depression

10.23.18

Kazia, Dana-Farber Cancer Institute Partner for Cancer

To investigate use of Kazia’s potential new therapy for brain cancer, GDC-0084, in breast cancer that has spread to the brain

10.22.18

Bio News | Clinical Trials | Collaborations & Alliances | Industry News | R&D

LSKB, Hengrui Enter Clinical Collaboration

To evaluate the safety & efficacy of LSKB's rivoceranib, known as apatinib or Aitan® in China with Hengrui's camrelizumab

10.22.18

cGMP Manufacture | Drug Development | R&D

Exelead at Contracting & Outsourcing 2018

Alexander Aust, Sr. Business Operations Associate at Exelead Biopharma, details the company's molecule to market capabilities

Videos

Bio News | Drug Development | Drug Discovery | Industry News | R&D

NeuroBo Pharmaceuticals Officially Launches

Will develop treatments for significant unmet patient needs including diabetic neuropathic pain and Alzheimer’s disease

10.18.18

MeiraGTx, Janssen Enter Research Collaboration

MeiraGTx will use their riboswitch technology to engineer gene therapy constructs encoding gene sequences from Janssen

10.18.18

Breaking News | Drug Discovery | Industry News | R&D

Charles River Awarded $95.7M NIH Contract

Will provide staffing for NIAID’s on-site vivarium and related research model operations

10.17.18

JHL Biotech Receives NMPA Approval

For Phase I & Phase III clinical trial applications for a proposed bevacizumab biosimilar, JHL1149, to treat forms of cancer

10.15.18

Login

Join

FOLLOW:

Subscribe Free

Magazine

eNewsletter

Checkout